Balance Sheet

Download CSV
Year Ending Dec 2025 (Update) Year Ending Dec 2024 (Update) Year Ending Dec 2023 (Update) Year Ending Dec 2022 (Update)
Cash 7.80 1.44 4.60 20.05
Cash and Short Term Investments 7.80 1.44 4.60 20.05
Accounts Receivable - Trade, Gross 0.31
Provision for Doubtful Accounts -0.15
Accounts Receivable - Trade, Net 0.16
Total Receivables, Net 0.16
Prepaid Expenses 0.93 1.86 2.28 5.73
Other Current Assets 0.00 0.01 0.01
Other Current Assets, Total 0.00 0.01 0.01
Total Current Assets 8.89 3.30 6.88 25.80
Machinery/Equipment - Gross 0.03 0.03
Other Property/Plant/Equipment - Gross 0.69
Property/Plant/Equipment, Total - Gross 0.73 0.03
Accumulated Depreciation, Total -0.03 -0.02
Property/Plant/Equipment, Total - Net 0.70 0.01
Goodwill, Net 1.79
Intangibles, Net 0.93
LT Investment - Affiliate Companies 0.40
LT Investments - Other
Long Term Investments 0.40
Other Long Term Assets 0.25 0.34 0.43 0.02
Other Long Term Assets, Total 0.25 0.34 0.43 0.02
Total Assets 12.96 3.65 7.32 25.82
Accounts Payable 4.27 4.13 4.63 2.08
Payable/Accrued
Accrued Expenses 1.68 1.70 4.63 4.51
Notes Payable/Short Term Debt 0.00 0.32 0.00 0.00
Current Portion of Long Term Debt/Capital Leases 0.00 1.25 9.16 7.70
Income Taxes Payable
Other Current Liabilities 22.63 14.47 0.62 1.29
Other Current liabilities, Total 22.63 14.47 0.62 1.29
Total Current Liabilities 28.58 21.86 19.05 15.59
Long Term Debt 0.00 5.01 0.00 2.82
Total Long Term Debt 0.00 5.01 0.00 2.82
Total Debt 0.00 6.58 9.16 10.53
Other Long Term Liabilities 0.32
Other Liabilities, Total 0.32
Total Liabilities 28.89 26.87 19.05 18.41
Convertible Preferred Stock – Non-Redeemable 0.00 0.00
Preferred Stock - Non Redeemable, Net 0.00 0.00
Common Stock 0.03 0.02 0.08 0.07
Common Stock, Total 0.03 0.02 0.08 0.07
Additional Paid-In Capital 290.93 255.04 241.33 230.34
Retained Earnings (Accumulated Deficit) -306.90 -278.27 -253.15 -223.00
Other Comprehensive Income 0.00 0.00
Other Equity, Total 0.00 0.00
Total Equity -15.94 -23.22 -11.73 7.41
Total Liabilities & Shareholders' Equity 12.96 3.65 7.32 25.82
Shares Outstanding – Common Stock Primary Issue 31.73 14.59 83.92 6.64
Total Common Shares Outstanding 31.73 14.59 83.92 6.64
Treasury Shares – Common Primary Issue 0.00 0.00 0.00 0.00
Shares Outstanding - Preferred Issue 1 0.00 0.00 3.00
Total Preferred Shares Outstanding 0.00 0.00 3.00
Treasury Shares – Primary Preferred Issue 0.00 0.00 0.00
Employees 29.00
Number of Common Shareholders 63.00 59.00 56.00 54.00
Total Current Assets less Inventory 8.89 3.30 6.88 25.80
Quick Ratio 0.31 0.15 0.36 1.66
Current Ratio 0.31 0.15 0.36 1.66
Net Debt -7.80 5.13 4.57 -9.53
Tangible Book Value -18.66 -23.22 -11.74 7.41
Tangible Book Value per Share -0.59 -1.59 -0.14 1.12
Total Operating Leases 0.63
Operating Lease Payments Due in Year 1 0.35
Operating Lease Payments Due in Year 2 0.28
Operating Lease Payments Due in Year 3 0.05
Operating Lease Payments Due in 2-3 Years 0.33
Standardized Operating Lease Payments Due in Year 6 and Beyond -0.05

In millions of USD (except for per share items)

Source: LSEG

Corporate Presentation

Click here to view our corporate presentation or on the image below
Corporate Presentation
IP Portfolio
View Our Pipeline
Contact NRx Pharmaceuticals